| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
colonization by MDR/XDR gram-negative bacteria leads to an increased
risk of subsequent bloodstream infections (BSI) in patients receiving
chemotherapy as a treatment for hematologic malignancies.
|Figure 1. Study flow diagram of the randomized controlled trial.|
|Table 1. Demographical and clinical baseline characteristics of patients by group in the study (randomized patients).|
|Figure 2. Evolution of rectal carriage of XDR/MDR Gram-negative bacteria over time with regard to decolonization with oral colistin in the study.|
|Figure 3. Probability of development of bloodstream infection in patients with intestinal colonization by MDR/XDR Gram-negative bacteria with regard to decolonization by oral colistin in the 90-day period after the intervention.|